Skip to main content
Clinical Trials/NCT00390377
NCT00390377UnknownPhase 2

A Study to Evaluate a Test for the Diagnosis of Breast Cancer Using X-Ray Diffraction of Hair Fibres.

Fermiscan Ltd2 sites in 1 country240 target enrollmentStarted: October 1, 2006Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Sponsor
Enrollment
240
Locations
2

Study Overview

Brief Summary

This study aims to perform x-ray diffraction analysis of blinded hair samples from women with a documented health status, to validate the previous findings of James et al who described that x-ray diffraction patterns of human hair can distinguish samples from healthy subjects from those of diseased subjects, specifically those suffering from breast cancer.

The primary hypothesis is that x-ray diffraction of hair can be used to distinguish hair from patients with confirmed breast cancer from subjects without detectable breast cancer.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
Single

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult women (aged >20) who are undergoing mammography, and
  • Who are willing and able to provide informed consent; and
  • Who have usable scalp hair

Exclusion Criteria

  • Women with a history of breast cancer ever or other cancers (excluding non-melanoma skin cancer and CIN: cervical intra-epithelial neoplasia) within 5 years.

Investigators

Sponsor
Fermiscan Ltd
Sponsor Class
Industry

Study Sites (2)

Loading locations...

Similar Trials